A medicine commonly used to treat intestinal worm infections has caught researchers’ attention for an unexpected reason. When combined with a targeted lung cancer drug, it helped slow the growth of tumors that had stopped responding to treatment in a study involving mice. The findings, published in PLOS ONE, raise an intriguing possibility for researchers …
Cancer cells can sometimes find a way to survive the very drugs designed to stop them, leaving researchers searching for new ways to fight back. Now, scientists investigating drug-resistant lung cancer have uncovered an unexpected possibility involving mebendazole, a medicine commonly used to treat parasitic worm infections. When researchers combined it with a targeted cancer …
A vaccine designed to help the body hunt down and destroy lung cancer cells has officially entered human trials, marking a major milestone in the fight against one of the deadliest diseases in the world. Researchers across seven countries have begun testing the treatment in patients, with hopes that it could dramatically improve survival rates and …
What if treating lung cancer one day felt less like enduring aggressive therapy and more like using a device that supports your breathing. That idea may sound distant, but researchers are now testing a gene therapy that is inhaled directly into the lungs. After early clinical results showed signs of tumor response in patients with …
The syringe contained no poison to kill cancer cells, no radioactive particles to burn through tissue, no harsh chemicals to ravage a patient’s body. Instead, it held something far more revolutionary: a set of molecular instructions that would transform a 67-year-old scientist’s immune system into a personalized cancer-hunting army. Janusz Racz didn’t know it as …
When millions lined up for COVID-19 vaccines during the pandemic, survival meant avoiding a deadly virus. Few could have imagined that same shot might offer protection against something else entirely. Researchers at two major cancer centers have stumbled onto a finding that could reshape how oncologists treat advanced disease. Patients with late-stage lung and skin …